Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel IR Rapid vs Conventional Titration in Acute Psychosis (FAST)
NCT00486798Phase 3Terminated
- Sponsor
- AstraZeneca
- Start
- May 2007
- Primary completion
- Aug 2007
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in psychotic disorder, schizophrenia, bipolar disorder (BD), sponsored by AstraZeneca. Started May 2007; status: terminated.
02
Drugs
quetiapine
03
Conditions
psychotic disorderschizophreniabipolar disorder (BD)
Beyond the preview
Go deeper on NCT00486798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00486798.